114
6
21
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T72026 |
p53-MDM2-IN-1
|
Mdm2; p53 | Apoptosis |
p53-MDM2-IN-1 (Example 30) 是一种 p53-MDM2/X 蛋白相互作用的抑制剂,Ki 值为 23.35 µM。p53-MDM2-IN-1 能用于抗肿瘤研究。 | |||
T67698 |
p53-Mdm2 inhibitor 4
|
Mdm2; p53 | Apoptosis |
p53-Mdm2 inhibitor 4 抑制 p53-MDM2 蛋白质-蛋白质相互作用。 | |||
T41084 |
MDM2-IN-21
MDM2-IN-21 |
||
MDM2-IN-21 is a potent MDM2 inhibitor. MDM2-IN-21 can be used for the research of cancer. | |||
T24440 |
MDM2-p53-IN-1b
MDM2-p53 inhibitor 1b,MDM2 p53 IN 1b |
||
MDM2-p53-IN-1b is the MDM2-p53 interaction inhibitor. | |||
T12351 |
p53 and MDM2 proteins-interaction-inhibitor (racemic)
p53-and-mdm2-proteins-interaction-inhibitor-racemic |
Others | Others |
p53 and MDM2 proteins-interaction-inhibitor (racemic) is an inhibitor of the interaction between p53 and MDM2 proteins. | |||
T18633 |
PROTAC MDM2 Degrader-3
|
Others | Others |
PROTAC MDM2 Degrader-3 is a compound that leverages PROTAC technology to degrade MDM2. It consists of a highly effective MDM2 inhibitor, a linker, and the MDM2 ligand for E3 ubiquitin ligase[1]. | |||
T11982 |
MDM2-IN-1
|
Others | Others |
MDM2-IN-1 is a synthetic MDM2-p53 interaction (MDM2) inhibitor and contains the trans (D-)configuration. | |||
T18631 |
PROTAC MDM2 Degrader-1
|
Others | Others |
PROTAC MDM2 Degrader-1 is a chemical compound that utilizes PROTAC technology to degrade MDM2. This compound is comprised of a highly effective MDM2 inhibitor, a linker, and the MDM2 ligand for E3 ubiquitin ligase[1]. | |||
T18634 |
PROTAC MDM2 Degrader-4
|
Others | Others |
PROTAC MDM2 Degrader-4 is a compound designed using PROTAC technology to degrade MDM2. It combines a powerful MDM2 inhibitor, a linker, and the MDM2 ligand for E3 ubiquitin ligase[1]. | |||
T18632 |
PROTAC MDM2 Degrader-2
|
Others | Others |
PROTAC MDM2 Degrader-2 is a compound designed utilizing PROTAC technology, functioning as a MDM2 degrader. Comprised of a highly potent inhibitor targeting MDM2, a linker, and the MDM2 ligand for E3 ubiquitin ligase, this compound facilitates the degradation of MDM2[1]. | |||
T12350 | p53 and MDM2 proteins-interaction-inhibitor dihydrochloride | Others | Others |
p53 and MDM2 proteins-interaction-inhibitor dihydrochloride is a interaction inhibitor between p53 and MDM2 proteins. | |||
T82179 |
HOXB7 8–25
MDM2 32-46 |
||
HOXB7 8–25 (MDM2 32-46)为来源于MDM2的肽段,能够特异性诱导抗原和激活肿瘤反应性的CD4+ T细胞。 | |||
T17874 |
Nutlin carboxylic acid
MDM2 ligand 1,E3 ligase Ligand 16 |
Others | Others |
Nutlin Carboxylic Acid (MDM2 ligand 1), derived from Nutlin 3, serves as an MDM2 ligand. It can be attached to a protein ligand via a linker to create PROTACs[1]. | |||
T79483 | MDM2/XIAP-IN-3 | ||
MDM2/XIAP-IN-3(化合物 3e)为MDM2/XIAP双重抑制剂,能够下调MDM2与XIAP蛋白水平,提升p53表达,进而抑制癌细胞增殖并诱导细胞凋亡。 | |||
T17873 |
(4R,5S)-nutlin carboxylic acid
E3 ligase Ligand 15,MDM2 ligand 2 |
Others | Others |
(4R,5S)-Nutlin Carboxylic Acid (MDM2 Ligand 2), a Nutlin 3-based MDM2 ligand, can be conjugated to a protein-binding ligand via a linker to create PROTACs[1]. | |||
T81830 | MDM2/XIAP-IN-1 | ||
MDM2/XIAP-IN-1(compound 14)是一种口服活性的MDM2/XIAP双靶点抑制剂,展现出抗癌活性,其IC50值为0.3 μM,适用于癌症研究。 | |||
T79012 | MDM2/XIAP-IN-2 | ||
MDM2/XIAP-IN-2为MDM2(murine double minute 2)和XIAP(x-linked inhibitor of apoptosis protein)的双重抑制剂, 能够降解MDM2并抑制XIAP mRNA的翻译,进而抑制癌细胞生长。该化合物在针对急性淋巴细胞白血病细胞系EU-1的研究中显示出优秀的抑制效果,IC50值为0.3 μM。 | |||
T72832 |
MDM2-p53-IN-16
|
||
MDM2-p53-IN-16 是MDM2-p53复合体抑制剂,其IC50值针对人MDM2-p532复合体为4.3 nM。该化合物能够重新激活p53,进而诱导多形性成胶质细胞瘤(GBM)细胞的凋亡和细胞周期阻滞,适用于癌症研究。 | |||
T74935 | MDM2/4-p53-IN-2 | ||
MDM2/4-p53-IN-2 (2q) 是一种有效的双重 MDM2/ MDM4抑制剂和 p53激活剂,作用于 MDM2-p53 和 MDM4-p53 复合物的 IC50值分别是 70.7 nM 和 81.4 nM。MDM2/4-p53-IN-2 可以调控细胞周期,诱导细胞凋亡(apoptosis),具有抗癌活性。 | |||
T74936 | MDM2/4-p53-IN-3 | ||
MDM2/4-p53-IN-3,一种针对MDM2/4-p53蛋白-蛋白相互作用(PPI)的抑制剂,IC50s分别为18.5 nM(MDM2-p53)与14.8 nM(MDM4-p53)。该化合物主要应用于癌症研究领域,特别是结肠癌的研究。 | |||
T17902 |
Nutlin-C1-amido-PEG4-C2-N3
E3 ligase Ligand-Linker Conjugates 48,MDM2 Ligand-Linker Conjugates 1 |
Others | Others |
Nutlin-C1-amido-PEG4-C2-N3 is a novel compound that functions as a ligand-linker conjugate for the E3 ligase. It is a synthesized molecule incorporating the MDM2 ligand derived from Nutlin 3, and a 4-unit PEG linker. This compound is specifically designed for utilization in PROTAC technology. | |||
T21578 |
NSC 66811
|
Mdm2 | Apoptosis |
NSC 66811 是一种MDM2-p53抑制剂,其结合到 MDM2 的Ki 值为 120 nM。 | |||
T78699 |
MDMX/MDM2-IN-2
|
||
MDMX/MDM2-IN-2 是一款p53-MDM2/MDMX双重抑制剂,具有高效性,其对MDM2和MDMX的Ki值分别为0.23 μM和2.45 μM。该化合物阻断p53与MDM2蛋白的相互作用,从而恢复p53功能,诱导细胞周期停滞与细胞凋亡。同时,MDMX/MDM2-IN-2抑制细胞迁移和侵袭,显示出潜在的抗肿瘤活性。 | |||
T1919 |
Tenovin-1
Tenovin 1 |
Mdm2; Dehydrogenase; Sirtuin; p53; Autophagy | Apoptosis; Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; Metabolism |
Tenovin-1 抑制 SirT1 和 SirT2 的蛋白质去乙酰化活性,并防止 MDM2 介导的 p53 降解,这涉及泛素化。它具有癌症的研究潜力。 | |||
T63748 | rel-MDM2/4-p53-IN-2 | ||
rel-MDM2/4-p53-IN-2 (2q) 是有效的双重 MDM2/MDM4 抑制剂和 p53 激活剂,能够作用于 MDM2-p53 复合物 (IC50: 70.7 nM) 和 MDM4-p53 复合物 (IC50: 81.4 nM)。rel-MDM2/4-p53-IN-2 能够调控细胞周期,诱导细胞凋亡(apoptosis),表现出抗癌效果。 | |||
T6610 |
XI-006
NSC 207895,可可碱 |
Mdm2; p53 | Apoptosis |
XI-006 (XI-006) 是一种DNA 破坏剂、抗肿瘤剂和p53的激活剂。 | |||
T63438 | rel-MDM2/4-p53-IN-3 | ||
rel-MDM2/4-p53-IN-3 是 MDM2/4-p53 蛋白质-蛋白质相互作用 (PPI) 抑制剂,能够作用于MDM2-p53、MDM4-p53,其IC50值分别为18.5 nM、14.8 nM。rel-MDM2/4-p53-IN-3 能够用于研究癌症,如结肠癌。 | |||
T1818 |
Tenovin-6
Tenovin 6 |
Dehydrogenase; Sirtuin; Autophagy | Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; Metabolism |
Tenovin-6 是 Tenovin-1 的类似物,能抑制二氢乳清酸脱氢酶。它也抑制纯化人 SIRT1、SIRT2 和 SIRT3 蛋白脱乙酰酶活性,IC50分别为 21 μM、10 μM 和 67 μM。它是一种 p53转录活性的激活剂。 | |||
T8480 |
Tenovin-6 Hydrochloride
|
Dehydrogenase; Sirtuin; HDAC; p53; Autophagy | Apoptosis; Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; Metabolism |
Tenovin-6 Hydrochloride 是 Tenovin-1 的类似物,能抑制二氢乳清酸脱氢酶。它是一种 p53转录活性的激活剂,抑制纯化人 SIRT1、SIRT2 和 SIRT3 蛋白脱乙酰酶活性,IC50分别为 21 μM、10 μM 和 67 μM。 | |||
T6023 |
Nutlin-3a
(-)-Nutlin-3,Nutlin-3a chiral,(−)-Nutlin-3 |
Apoptosis; E1/E2/E3 Enzyme; Autophagy | Apoptosis; Autophagy; Ubiquitination |
Nutlin-3a ((−)-Nutlin-3) 是 Nutlin-3 的活性对映体,是一种 MDM2抑制剂,可抑制 MDM2-p53相互作用,稳定 p53 蛋白,从而诱导细胞自噬和凋亡,有潜力研究 TP53野生型卵巢癌。 | |||
T6614 |
Nutlin-3b
(+)-Nutlin-3,4-[[(4R,5S)-4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮 |
Mdm2; E1/E2/E3 Enzyme | Apoptosis; Ubiquitination |
Nutlin-3b ((+)-Nutlin-3) 是一种 p53/MDM2 拮抗剂或抑制剂,IC50为 13.6 μM。它与 MDM2 的结合活性比 Nutlin-3a 低 150 倍。 | |||
T2158 |
Nutlin-3
Nutlin3 |
E1/E2/E3 Enzyme | Ubiquitination |
Nutlin-3 是一种 MDM2 拮抗剂,抑制 MDM2-p53 相互作用 ,Ki 为 90 nM,并激活 p53。 | |||
T16771 |
RO-5963
|
Mdm2; p53 | Apoptosis |
RO-5963是p53-MDM2和p53-MDMX 的双重抑制剂(IC50s:~17nM 和~24nM)。 | |||
TQ0127 |
Navtemadlin
AMG232,CS-1300 |
Mdm2; E1/E2/E3 Enzyme | Apoptosis; Ubiquitination |
Navtemadlin (AMG232) 是一种有效的、选择性的、可口服的 p53-MDM2 相互作用抑制剂,IC50值为 0.6 nM。它以 0.045 nM 的 Kd 与 MDM2 结合。 | |||
T6254 |
Idasanutlin
RG7388,Ro 5503781,依达奴林 |
Mdm2; E1/E2/E3 Enzyme | Apoptosis; Ubiquitination |
Idasanutlin (Ro 5503781) 是一种有效且特异性的 p53-MDM2 抑制剂 ,IC50值为 6 nM。 | |||
T3653 |
MX69
|
Mdm2; E1/E2/E3 Enzyme; IAP | Apoptosis; Ubiquitination |
MX69 是用于抗癌研究的一种MDM2/XIAP 抑制剂。 | |||
T14303 |
Alrizomadlin
APG-115,AA-115 |
Mdm2 | Apoptosis |
Alrizomadlin (APG-115) 是一种具有口服活性的 MDM2 抑制剂,IC50 为 3.8 nM,Ki 分别为 1 nM[1]。 Alrizomadlin 阻断 MDM2 和 p53 的相互作用,并以 p53 依赖性方式诱导细胞周期停滞和细胞凋亡。 | |||
T21773 |
SP-141
SP 141 |
Mdm2 | Apoptosis |
SP-141 是一种 MDM2 抑制剂,可促进 MDM2 自身泛素化和降解,具有抗癌活性。 | |||
TQ0231 |
NVP-CGM097
CGM097 |
Mdm2; E1/E2/E3 Enzyme | Apoptosis; Ubiquitination |
NVP-CGM097 (CGM097) 是一种选择性MDM2抑制剂,对hMDM2的IC50为 1.7 nM。 | |||
T6585 |
SAR405838
MI773,MI 773,MI-77301,MI-773 |
Mdm2; E1/E2/E3 Enzyme | Apoptosis; Ubiquitination |
SAR405838 (MI 773) 是 MI-773 的类似物,具有抗肿瘤活性。它是一种高效、选择性的MDM2-p53相互作用抑制剂,与 MDM2 结合的Ki 值为 0.88 nM。 | |||
T6965 |
RG7112
RG-7112,RG 7112,RO5045337 |
Mdm2; E1/E2/E3 Enzyme | Apoptosis; Ubiquitination |
RG7112 (RO5045337) 是一种口服生物可利用的选择性 p53-MDM2 抑制剂。 | |||
T3517 |
RO8994
|
Mdm2; E1/E2/E3 Enzyme; p53 | Apoptosis; Ubiquitination |
RO8994是一种高效且特异性的螺吲哚酮小分子 MDM2 抑制剂,MTT 增殖试验和HTRF 结合试验的IC50 为 20 nM 和 5 nM。 | |||
T11980 |
MD-224
|
Mdm2; E1/E2/E3 Enzyme; PROTACs | Apoptosis; PROTAC; Ubiquitination |
MD-224是一种基于蛋白水解靶向嵌合体(PROTAC)概念的高效、高效的MDM2降解剂,是一类新型抗癌剂。 | |||
T5555 |
Siremadlin
NVP-HDM 201 |
E1/E2/E3 Enzyme | Ubiquitination |
Siremadlin (NVP-HDM 201) 是一种有效的、可口服的、高度特异性的 p53-MDM2 相互作用抑制剂。 | |||
T28509 |
RDR03871
RDR 03871,ZINC20458540,RDR-03871 |
Mdm2 | Apoptosis |
RDR03871是一种 MDM2抑制剂。 | |||
T5461 |
GNE-6640
|
DUB | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Ubiquitination |
GNE 6640 是一种选择性泛素特异性肽酶 7(USP7)的非共价抑制剂,其对全长USP7、USP7 催化结构域、全长USP43 以及 Ub-MDM2 的IC50值分别为 0.75 μM、0.43 μM、20.3 μM 和 0.23 μM。 | |||
T28078 |
MMRi64
|
Apoptosis; Mdm2; p53 | Apoptosis |
MMRi64 是 Mdm2-MdmX E3 连接酶活性的特异性抑制剂。MMRi64 能有效诱导 p53 积累,并诱导白血病/淋巴瘤细胞中 p53 途径的凋亡,破坏 Mdm2-MdmX 相互作用, 下调白血病细胞中的 Mdm2 和 MdmX。MMRi64 MMRi64 可用于癌症研究。 | |||
T6149 |
YH239-EE
|
Apoptosis; E1/E2/E3 Enzyme | Apoptosis; Ubiquitination |
YH239-EE 是 YH239 的乙酯,是 p53-MDM2 拮抗剂和凋亡诱导剂。 | |||
T12040 |
Milademetan
RAIN-32,DS-3032,DS3032b |
Mdm2; Others | Apoptosis; Others |
Milademetan (DS-3032) 是一种具有口服活性和有效性的 MDM2 抑制剂,具有抗肿瘤活性,诱导 G1 细胞周期阻滞、衰老和凋亡。Milademetan 可用于研究急性髓系白血病和实体肿瘤。 | |||
T1493 |
BH3I-1
BHI1 |
BCL; E1/E2/E3 Enzyme | Apoptosis; Ubiquitination |
BH3I-1 (BHI1) 是一种Bcl-2家族拮抗剂,作用于p53/mDM2,Kd 为 5.3 μM。它抑制BakBH3 肽与Bcl-xL 结合,Ki 为 2.6 μM。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6S1780 |
Protosappanin B
原苏木素B,Q-100961,FT-0689654 |
Apoptosis | Apoptosis |
Protosappanin B (Q-100961) 是从苏木中提取的一种多酚类天然产物,具有抗肿瘤作用。它通过激活 MDM2 依赖性泛素化过程诱导 p53 蛋白降解。它显著提高细胞活力,抑制细胞凋亡并上调生长相关蛋白 43 的表达。 | |||
T2140 |
Parthenolide
(-)-Parthenolide,小白菊内酯 |
Apoptosis; Mitophagy; NF-κB; HDAC; Autophagy | Apoptosis; Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; NF-κB |
Parthenolide ((-)-Parthenolide) 是一种从药草短舌匹菊中发现的倍半萜内酯。 它抑制NF-κB 活化,有抗炎活性。它还可抑制HDAC1蛋白,但不影响其他I/II 类HDAC。 | |||
T6717 |
Vanillin
Lioxin,m-Methoxy-p-hydroxybenzaldehyde,香草醛,Zimco,p-Vanillin,p-Hydroxy-m-methoxybenzaldehyde,香兰素,FEMA 3107 |
Others; Endogenous Metabolite | Metabolism; Others |
Vanillin (Zimco) 是一种天然产物,是从香草豆中提取的单个分子,是香水,食品和药物中广泛使用的气味。 | |||
T22857 |
Illudin S
|
Apoptosis; DNA Alkylator/Crosslinker; Antifungal | Apoptosis; DNA Damage/DNA Repair; Microbiology/Virology |
Illudin S (ILS)是一种真菌倍半萜次生代谢物,具有很强的遗传毒性和细胞毒性 | |||
T2179 |
Triptolide
PG490,NSC 163062,雷公藤甲素 |
Apoptosis; Mdm2; HSP; NF-κB | Apoptosis; Cytoskeletal Signaling; Metabolism; NF-κB |
Triptolide (PG490) 属于三环二萜类天然产物,是一种 NF-κB 活化的抑制剂。Triptolide 具有免疫抑制、抗风湿、抗炎、抗增殖和抗肿瘤活性。 | |||
TN4107 | Ganoderic acid X | ERK; Mdm2; MAPK; Caspase; Topoisomerase; JNK; p53 | Apoptosis; DNA Damage/DNA Repair; MAPK; Proteases/Proteasome |
Ganoderic acid X is a potential Mdm2 inhibitor(K(i) = 16nM). It is a potential anticancer drug, inhibits topoisomerases and induces apoptosis of cancer cells. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-02630 |
MDM2 Protein, Mouse, Recombinant (His)
|
Mouse | E. coli |
E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as a ubiquitin ligase E3 toward itself, ARRB1 and ARBB2. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitina... | |||
TMPY-04753 |
IRE1 Protein, Human, Recombinant (aa 465-977)
hIRE1p,endoplasmic reticulum to nucleus signaling 1,IRE1P,IR... |
Human | Baculovirus-Insect Cells |
Endoplasmic reticulum stress and hypoxia are necessary components of malignant tumors growth and suppression of ERN1 (from endoplasmic reticulum to nuclei-1) signalling pathway, which is linked to the apoptosis and cell death processes, significantly decreases proliferative processes. An enhanced expression of TP53 gene in ERN1 knockdown glioma cells correlates with the decreased level of ubiquitin ligase MDM2 and increased expression level of USP7 which deubiquitinates TP53 and MDM2 and induces... | |||
TMPY-04413 |
IRE1 Protein, Human, Recombinant (aa 465-977, His & GST)
hIRE1p,endoplasmic reticulum to nucleus signaling 1,IRE1P,IR... |
Human | Baculovirus-Insect Cells |
Endoplasmic reticulum stress and hypoxia are necessary components of malignant tumors growth and suppression of ERN1 (from endoplasmic reticulum to nuclei-1) signalling pathway, which is linked to the apoptosis and cell death processes, significantly decreases proliferative processes. An enhanced expression of TP53 gene in ERN1 knockdown glioma cells correlates with the decreased level of ubiquitin ligase MDM2 and increased expression level of USP7 which deubiquitinates TP53 and MDM2 and induces... | |||
TMPY-01463 |
USP7 Protein, Human, Recombinant (aa 208-560, His & GST)
ubiquitin specific peptidase 7 (herpes virus-associated),HAU... |
Human | Baculovirus-Insect Cells |
Ubiquitin carboxyl-terminal hydrolase 7, also known as Ubiquitin thioesterase 7, Herpesvirus-associated ubiquitin-specific protease, Ubiquitin-specific-processing protease 7, USP7 and HAUSP, is a widely expressed protein that belongs to the peptidase C19 family. USP7 is a member of the family of deubiquitinating enzymes. It is involved in the regulation of stress response pathways, epigenetic silencing and the progress of infections by DNA viruses. USP7 is a protein with a cysteine peptidase cor... | |||
TMPH-02286 |
USP7 Protein, Human, Recombinant (His & Myc & SUMO)
|
Human | E. coli |
Hydrolase that deubiquitinates target proteins such as FOXO4, p53/TP53, MDM2, ERCC6, DNMT1, UHRF1, PTEN, KMT2E/MLL5 and DAXX. Together with DAXX, prevents MDM2 self-ubiquitination and enhances the E3 ligase activity of MDM2 towards p53/TP53, thereby promoting p53/TP53 ubiquitination and proteasomal degradation. Deubiquitinates p53/TP53, preventing degradation of p53/TP53, and enhances p53/TP53-dependent transcription regulation, cell growth repression and apoptosis. Deubiquitinates p53/TP53 and ... | |||
TMPH-01855 |
PEX19 Protein, Human, Recombinant (GST)
|
Human | E. coli |
Necessary for early peroxisomal biogenesis. Acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Binds and stabilizes newly synthesized PMPs in the cytoplasm by interacting with their hydrophobic membrane-spanning domains, and targets them to the peroxisome membrane by binding to the integral membrane protein PEX3. Excludes CDKN2A from the nucleus and prevents its interaction with MDM2, which results in active degradation of TP53. | |||
TMPJ-00703 |
Gankyrin Protein, Human, Recombinant
PSMD10,Gankyrin,26S Proteasome Non-ATPase Regulator... |
Human | E. coli |
Gankyrin is a multicatalytic proteinase oncoprotein consists of 7 ankyrin repeats. Gankyrin overexpressed in most hepatocellular carcinomas. Gankyrin is involved in theregulation of the phosphorylation of the retinoblastoma protein by CDK4 to enhance the ubiquitinylation of p53 by MDM2. Gankyrin is also involved in progression of esophageal squamous cell carcinoma. Gankyrin plays an oncogenic role especially in early stages of human epatocarcinogenesis. | |||
TMPY-01464 |
USP7 Protein, Human, Recombinant (aa 208-560)
TEF1,HAUSP,ubiquitin specific peptidase 7 (herpes virus-asso... |
Human | Baculovirus-Insect Cells |
Ubiquitin carboxyl-terminal hydrolase 7, also known as Ubiquitin thioesterase 7, Herpesvirus-associated ubiquitin-specific protease, Ubiquitin-specific-processing protease 7, USP7 and HAUSP, is a widely expressed protein that belongs to the peptidase C19 family. USP7 is a member of the family of deubiquitinating enzymes. It is involved in the regulation of stress response pathways, epigenetic silencing and the progress of infections by DNA viruses. USP7 is a protein with a cysteine peptidase cor... | |||
TMPY-01465 |
USP7 Protein, Human, Recombinant (His & GST)
HAUSP,ubiquitin specific peptidase 7 (herpes virus-associate... |
Human | Baculovirus-Insect Cells |
Ubiquitin carboxyl-terminal hydrolase 7, also known as Ubiquitin thioesterase 7, Herpesvirus-associated ubiquitin-specific protease, Ubiquitin-specific-processing protease 7, USP7 and HAUSP, is a widely expressed protein that belongs to the peptidase C19 family. USP7 is a member of the family of deubiquitinating enzymes. It is involved in the regulation of stress response pathways, epigenetic silencing and the progress of infections by DNA viruses. USP7 is a protein with a cysteine peptidase cor... | |||
TMPH-02899 |
VRK1 Protein, Mouse, Recombinant (His & Myc)
|
Mouse | E. coli |
Serine/threonine kinase involved in Golgi disassembly during the cell cycle: following phosphorylation by PLK3 during mitosis, required to induce Golgi fragmentation. Acts by mediating phosphorylation of downstream target protein. Phosphorylates 'Thr-18' of p53/TP53 and may thereby prevent the interaction between p53/TP53 and MDM2. Phosphorylates casein and histone H3. Phosphorylates BANF1: disrupts its ability to bind DNA, reduces its binding to LEM domain-containing proteins and causes its rel... | |||
TMPH-00900 |
Human adenovirus C serotype 5 Early E1A protein (His & SUMO)
|
HAdV-5 | E. coli |
Plays a role in viral genome replication by driving entry of quiescent cells into the cell cycle. Stimulation of progression from G1 to S phase allows the virus to efficiently use the cellular DNA replicating machinery to achieve viral genome replication. E1A protein has both transforming and trans-activating activities. Induces the disassembly of the E2F1 transcription factor from RB1 by direct competition for the same binding site on RB1, with subsequent transcriptional activation of E2F1-regu... | |||
TMPY-02228 |
p53 Protein, Cynomolgus, Recombinant
tumor protein p53,p53,TP53 |
Cynomolgus | E. coli |
p53, also known as Tp53, is a DNA-binding protein which belongs to the p53 family. It contains transcription activation, DNA-binding, and oligomerization domains. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines, where it's believed to contribute to transformation and malignancy. p53 (TP53) is a transcription factor whose protein levels and post-translational modification state alter in response to cellular stress (such as DNA damag... | |||
TMPY-01125 |
MDMX Protein, Human, Recombinant (His)
MRP1,MDM4, p53 regulator,HDMX,MDMX |
Human | E. coli |
MDM4 (MDM4 Regulator Of P53, also known as MDMX) is a Protein Coding gene. This gene encodes a nuclear protein that contains a p53 binding domain at the N-terminus and a RING finger domain at the C-terminus and shows structural similarity to p53-binding protein MDM2. MDM4 is a promising target for cancer therapy, as it is undetectable in most normal adult tissues but often upregulated in cancer cells to dampen p53 tumor-suppressor function. MDM4, an essential negative regulator of the P53 tumor ... | |||
TMPY-04560 |
VRK1 Protein, Human, Recombinant (His & GST)
PCH1A,PCH1,vaccinia related kinase 1 |
Human | Baculovirus-Insect Cells |
VRK1 is a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. Serine/threonine protein kinases are tumor suppressor that controls the activity of AMP-activated protein kinase family members, thereby playing a role in various processes such as cell metabolism, cell polarity, apoptosis and DNA damage response. VRK1 contains 1 protein kinase domain and localizes to the nucleus. VRK1 gene is widely expressed in human tissues and has increased expression in activel... | |||
TMPY-02391 |
SUMO1 Protein, Human, Recombinant (His)
small ubiquitin-like modifier 1,SMT3C,SMT3,SMT3H3,UBL1,SENP<... |
Human | E. coli |
Small ubiquitin-like modifier protein (SUMO) modification is a highly dynamic process, catalyzed by SUMO-specific activating (E1), conjugating (E2) and ligating (E3) enzymes, and reversed by a family of SUMO-specific proteases (SENPs). Small ubiquitin-like modifier 1 (SUMO1) is a member of the superfamily of ubiquitin-like proteins. Despite its structural similarity with ubiquitin, SUMO1 does not seem to play any role in protein degradation. SUMO1 plays an important role in modulation of NOX act... | |||
TMPH-02549 |
FHIT Protein, Mouse, Recombinant (His)
|
Mouse | E. coli |
Possesses dinucleoside triphosphate hydrolase activity. Cleaves P(1)-P(3)-bis(5'-adenosyl) triphosphate (Ap3A) to yield AMP and ADP. Can also hydrolyze P(1)-P(4)-bis(5'-adenosyl) tetraphosphate (Ap4A), but has extremely low activity with ATP. Exhibits adenylylsulfatase activity, hydrolyzing adenosine 5'-phosphosulfate to yield AMP and sulfate. Exhibits adenosine 5'-monophosphoramidase activity, hydrolyzing purine nucleotide phosphoramidates with a single phosphate group such as adenosine 5'monop... | |||
TMPY-02211 |
USP5 Protein, Human, Recombinant (His)
ISOT,ubiquitin specific peptidase 5 (isopeptidase T) |
Human | Baculovirus-Insect Cells |
Ubiquitin carboxyl-terminal hydrolase 5, also known as Deubiquitinating enzyme 5, Isopeptidase T, Ubiquitin thiolesterase 5, Ubiquitin-specific-processing protease 5, ISOT and USP5, is a member of the peptidase C19 family. USP5 contains 2 UBA domains and one UBP-type zinc finger. The UBP-type zinc finger domain interacts selectively with an unmodified C-terminus of the proximal ubiquitin. Both UBA domains are involved in polyubiquitin recognition. The UBP-type zinc finger domain crystallizes as ... | |||
TMPY-04751 |
VRK1 Protein, Human, Recombinant
PCH1,vaccinia related kinase 1,PCH1A |
Human | Baculovirus-Insect Cells |
VRK1 is a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. Serine/threonine protein kinases are tumor suppressor that controls the activity of AMP-activated protein kinase family members, thereby playing a role in various processes such as cell metabolism, cell polarity, apoptosis and DNA damage response. VRK1 contains 1 protein kinase domain and localizes to the nucleus. VRK1 gene is widely expressed in human tissues and has increased expression in activel... | |||
TMPH-02855 |
PML Protein, Mouse, Recombinant (His & Myc)
|
Mouse | E. coli |
Functions via its association with PML-nuclear bodies (PML-NBs) in a wide range of important cellular processes, including tumor suppression, transcriptional regulation, apoptosis, senescence, DNA damage response, and viral defense mechanisms. Acts as the scaffold of PML-NBs allowing other proteins to shuttle in and out, a process which is regulated by SUMO-mediated modifications and interactions. Positively regulates p53/TP53 by acting at different levels (by promoting its acetylation and phosp... | |||
TMPH-00855 |
RPS3 Protein, Human, Recombinant (His)
|
Human | E. coli |
Involved in translation as a component of the 40S small ribosomal subunit. Has endonuclease activity and plays a role in repair of damaged DNA. Cleaves phosphodiester bonds of DNAs containing altered bases with broad specificity and cleaves supercoiled DNA more efficiently than relaxed DNA. Displays high binding affinity for 7,8-dihydro-8-oxoguanine (8-oxoG), a common DNA lesion caused by reactive oxygen species (ROS). Has also been shown to bind with similar affinity to intact and damaged DNA. ... | |||
TMPH-02288 |
UBE2D3 Protein, Human, Recombinant (His & SUMO)
|
Human | E. coli |
Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-11'-, as well as 'Lys-48'-linked polyubiquitination. Cooperates with the E2 CDC34 and the SCF(FBXW11) E3 ligase complex for the polyubiquitination of NFKBIA leading to its subsequent proteasomal degradation. Acts as an initiator E2, priming the phosphorylated NFKBIA target at positions 'Lys-21' and/or 'Lys-22' with a monoubiquitin. Ubiquitin chain elongation is then performed by... |